Recent News

• 02.20.2025 - SpringWorks Therapeutics Q4 2024 Earnings Conference Call
• 02.20.2025 - SpringWorks Therapeutics Q4 2024 Earnings Conference Call
• 02.20.2025 - SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates
• 02.20.2025 - SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates
• 02.20.2025 - SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates
• 02.19.2025 - SpringWorks Therapeutics and Jewelry Designer Jennifer Fisher Team Up to Encourage People with Desmoid Tumors to Take Action Before Their Tumor Takes Over
• 02.19.2025 - SpringWorks Therapeutics and Jewelry Designer Jennifer Fisher Team Up to Encourage People with Desmoid Tumors to Take Action Before Their Tumor Takes Over
• 02.12.2025 - UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

Recent Filings

• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - 144 Report of proposed sale of securities
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.12.2025 - 8-K Current report
• 02.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.12.2025 - EX-99.1 EX-99.1